Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Opiate-induced changes in brain adenosine levels and narcotic drug responses.

Wu M, Sahbaie P, Zheng M, Lobato R, Boison D, Clark JD, Peltz G.

Neuroscience. 2013 Jan 3;228:235-42. doi: 10.1016/j.neuroscience.2012.10.031. Epub 2012 Oct 22.

2.

Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.

Capasso A, Gallo C.

Curr Drug Saf. 2009 May;4(2):97-102.

PMID:
19442100
3.

A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behavior.

Brown RM, Short JL, Cowen MS, Ledent C, Lawrence AJ.

Neuropsychopharmacology. 2009 Mar;34(4):844-56. doi: 10.1038/npp.2008.72. Epub 2008 Jun 4.

4.

micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.

Madhavan A, He L, Stuber GD, Bonci A, Whistler JL.

J Neurosci. 2010 Mar 3;30(9):3276-86. doi: 10.1523/JNEUROSCI.4634-09.2010.

5.

Actions of narcotics on brain dopamine metabolism and their relevance for "psychomotor" effects.

Kuschinsky K.

Arzneimittelforschung. 1976 Apr;26(4):563-7. Review.

PMID:
8059
6.

Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.

Sora I, Elmer G, Funada M, Pieper J, Li XF, Hall FS, Uhl GR.

Neuropsychopharmacology. 2001 Jul;25(1):41-54.

7.
8.

Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation.

Morón JA, Gullapalli S, Taylor C, Gupta A, Gomes I, Devi LA.

Neuropsychopharmacology. 2010 Mar;35(4):955-66. doi: 10.1038/npp.2009.199. Epub 2009 Dec 2.

9.

Morphine tolerance and dependence in the nociceptin receptor knockout mice.

Mamiya T, Noda Y, Ren X, Nagai T, Takeshima H, Ukai M, Nabeshima T.

J Neural Transm (Vienna). 2001;108(12):1349-61.

PMID:
11810400
10.

Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.

Papaleo F, Ghozland S, Ingallinesi M, Roberts AJ, Koob GF, Contarino A.

Neuropsychopharmacology. 2008 Nov;33(12):2878-87. doi: 10.1038/npp.2008.8. Epub 2008 Feb 20.

11.
12.

From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics.

Chu LF, Liang DY, Li X, Sahbaie P, D'arcy N, Liao G, Peltz G, David Clark J.

Pharmacogenet Genomics. 2009 Mar;19(3):193-205. doi: 10.1097/FPC.0b013e328322e73d.

13.

Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice.

Divin MF, Holden Ko MC, Traynor JR.

Eur J Pharmacol. 2008 Mar 31;583(1):48-55. doi: 10.1016/j.ejphar.2008.01.004. Epub 2008 Jan 24.

14.
16.
17.

Importance of GluA1 subunit-containing AMPA glutamate receptors for morphine state-dependency.

Aitta-aho T, Möykkynen TP, Panhelainen AE, Vekovischeva OY, Bäckström P, Korpi ER.

PLoS One. 2012;7(5):e38325. doi: 10.1371/journal.pone.0038325. Epub 2012 May 31.

18.

Decrease of morphine-induced reward effects and withdrawal symptoms in mice overexpressing gamma-aminobutyric acid transporter I.

Hu JH, Yang N, Ma YH, Zhou XG, Zhang XY, Jiang J, Mei ZT, Fei J, Guo LH.

J Neurosci Res. 2003 Nov 15;74(4):614-21.

PMID:
14598306
19.

Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice.

Zhang Y, Li H, Li Y, Sun X, Zhu M, Hanley G, Lesage G, Yin D.

Neurosci Lett. 2011 Feb 1;489(1):43-7. doi: 10.1016/j.neulet.2010.11.063. Epub 2010 Dec 2.

20.

Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.

Stinus L, Cador M, Zorrilla EP, Koob GF.

Neuropsychopharmacology. 2005 Jan;30(1):90-8.

Supplemental Content

Support Center